|
Index of reports
> Cases resulting in a serious event (23)
> Cases with Abnormal Behaviour (7)
Below is the selection of adverse event reports related to MS Contin (Morphine) that includes cases resulting in a serious event where reactions include abnormal behaviour.
Adverse event in 42 year old female receiving MS Contin (Morphine)
Reported by a physician from United States on 2007-06-27
Patient: 42 year old female
Adverse reactions / side effects: Confusional State, Dyspnoea, Neuropathy Peripheral, Abnormal Behaviour, Drug Interaction, Mood Swings, Disease Progression
Suspect drug(s):
MS Contin
Dosage: 15 mg qd po
Administration route: Oral
Indication: Complex Regional Pain Syndrome
Start date: 2006-10-01
Namenda
Dosage: 10 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-12-13
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-12-14
End date: 2006-12-20
Namenda
Dosage: 5 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-11-01
End date: 2006-01-01
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Namenda
Dosage: 15 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Other drugs received by patient: Warfarin Sodium; Crestor; Darvocet; Spiriva; Levoxyl; Oxygen
Adverse event in male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-06-22
Patient: male
Adverse reactions / side effects: Abnormal Behaviour, Disorientation
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin
Dosage: unk mg, see text
Indication: Procedural Pain
Oxymorphone Hydrochloride
Dosage: unk, unk
Indication: Bone Pain
Adverse event in male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-06-22
Patient: male
Adverse reactions / side effects: Abnormal Behaviour, Disorientation
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin
Dosage: unk mg, see text
Indication: Procedural Pain
Oxymorphone Hydrochloride
Dosage: unk, unk
Indication: Bone Pain
Adverse event in female receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-06-22
Patient: female
Adverse reactions / side effects: Abnormal Behaviour, Disorientation
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin (Morphine)
Adverse event in male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-06-22
Patient: male
Adverse reactions / side effects: Abnormal Behaviour, Disorientation
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin (Morphine)
Adverse event in 42 year old female receiving MS Contin (Morphine)
Reported by a physician from United States on 2007-05-09
Patient: 42 year old female
Adverse reactions / side effects: Back Pain, Confusional State, Dyspnoea, Abnormal Behaviour, Condition Aggravated, Drug Interaction, Cognitive Disorder, Amnesia, Complex Regional Pain Syndrome, Neuropathy Peripheral, Mood Swings
Suspect drug(s):
MS Contin
Dosage: 15 mg qd po
Administration route: Oral
Indication: Complex Regional Pain Syndrome
Start date: 2006-10-01
Namenda
Dosage: 10 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-12-13
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-12-14
End date: 2006-12-20
Namenda
Dosage: 5 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-11-01
End date: 2006-01-01
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Namenda
Dosage: 15 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Other drugs received by patient: Warfarin Sodium; Crestor; Darvocet; Spiriva; Levoxyl; Oxygen
Adverse event in 42 year old female receiving MS Contin (Morphine)
Reported by a physician from United States on 2007-03-13
Patient: 42 year old female
Adverse reactions / side effects: Back Pain, Confusional State, Dyspnoea, Abnormal Behaviour, Drug Interaction, Amnesia, Disease Progression, Hyperaesthesia, Neuropathy Peripheral, Mood Swings
Suspect drug(s):
MS Contin
Dosage: 15 mg qd po
Administration route: Oral
Indication: Complex Regional Pain Syndrome
Start date: 2006-10-01
Namenda
Dosage: 10 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-12-13
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-12-14
End date: 2006-12-20
Namenda
Dosage: 5 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-11-01
End date: 2006-01-01
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Namenda
Dosage: 15 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Other drugs received by patient: Warfarin Sodium; Crestor; Darvocet (Propoxyphene / Acetaminophen); Spiriva; Levoxyl; Oxygen
|
